MedTech Acquisition Corporation announced that it has entered into a subscription agreements for a private placement of 1,785,502 series A convertible preferred shares at an issue price of $10 per share for gross proceeds of up to $17,855,020 on June 7, 2023. Upon issuance, each share of Series A Convertible Preferred Stock will be initially convertible into one share of Common Stock. The closing of the purchase and sale of the Series A Convertible Preferred Stock will occur concurrently with the closing of the Business Combination and is subject to the conditions in the Subscription Agreements, including the filing of the Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock.